| SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
EVL |
EVL, RNB6: Ena/VASP-like protein |
6.145 |
Evidence |
|
| BMF |
BMF: Bcl-2-modifying factor |
RTN4 |
RTN4, KIAA0886, My043, NOGO, SP1507: Reticulon-4 |
6.145 |
Evidence |
|
| PLEC1 |
PLEC1: Plectin-1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
6.145 |
Evidence |
|
| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
C6orf21 |
LY6G6F, C6orf21, G6F, LY6G6D, NG32: Lymphocyte antigen 6 complex locus protein G |
6.145 |
Evidence |
|
| PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
TJP2 |
TJP2, X104, ZO2: Tight junction protein ZO-2 |
6.145 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
GRB10 |
IPI00012752 |
6.145 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
EVL |
EVL, RNB6: Ena/VASP-like protein |
6.145 |
Evidence |
|
| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
IRS4 |
IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
ADAM15 |
ADAM15, MDC15: ADAM 15 precursor |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
GRB10 |
IPI00012752 |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
6.145 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
6.145 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
PTPRA |
IPI00032333 |
6.145 |
Evidence |
|
| GSK3B |
GSK3B: Glycogen synthase kinase-3 beta |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
6.145 |
Evidence |
|